The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease
dc.contributor.author | Kuloglu, Z | |
dc.contributor.author | Kansu, A | |
dc.contributor.author | Selbuz, S | |
dc.contributor.author | Kalayci, AG | |
dc.contributor.author | Sahin, G | |
dc.contributor.author | Kirsaclioglu, CT | |
dc.contributor.author | Demirören, K | |
dc.contributor.author | Dalgiç, B | |
dc.contributor.author | Kasirga, E | |
dc.contributor.author | Önal, Z | |
dc.contributor.author | Islek, A | |
dc.contributor.author | Eren, E | |
dc.contributor.author | Hosnut, FÖ | |
dc.contributor.author | Urganci, N | |
dc.contributor.author | Yaman, A | |
dc.contributor.author | Özkan, T | |
dc.contributor.author | Bozbulut, E | |
dc.contributor.author | Dogan, G | |
dc.contributor.author | Eksi Bozbulut, N | |
dc.contributor.author | Dogan, G | |
dc.contributor.author | Durmaz Ugurcan, Ö | |
dc.contributor.author | Usta, AM | |
dc.contributor.author | Arslan, D | |
dc.contributor.author | Akçam, M | |
dc.contributor.author | Isik, IA | |
dc.contributor.author | Ecevit, ÇÖ | |
dc.contributor.author | Usta, Y | |
dc.contributor.author | Özgür, T | |
dc.contributor.author | Özçay, F | |
dc.contributor.author | Balamtekin, N | |
dc.contributor.author | Öztürk, Y | |
dc.contributor.author | Balamtekin, N | |
dc.contributor.author | Öztürk, Y | |
dc.contributor.author | Cantez, S | |
dc.contributor.author | Gülerman, F | |
dc.contributor.author | Üstündag, GH | |
dc.contributor.author | Emiroglu, HH | |
dc.contributor.author | Karacabey, N | |
dc.contributor.author | Comba, A | |
dc.contributor.author | Erdemir, G | |
dc.contributor.author | Aydogan, AU | |
dc.contributor.author | Gökçe, S | |
dc.contributor.author | Kuyum, P | |
dc.contributor.author | Gülsan, M | |
dc.contributor.author | Tosun, MS | |
dc.contributor.author | Tokgöz, Y | |
dc.contributor.author | Güven, B | |
dc.contributor.author | Yüksekkaya, H | |
dc.contributor.author | Tümgör, G | |
dc.contributor.author | Eren, M | |
dc.contributor.author | Baran, M | |
dc.contributor.author | Gümüs, M | |
dc.contributor.author | Canan, O | |
dc.contributor.author | Kocamaz, H | |
dc.contributor.author | Gerenli, N | |
dc.contributor.author | Çakir, M | |
dc.contributor.author | Agin, M | |
dc.contributor.author | Hizli, S | |
dc.contributor.author | Dogan, Y | |
dc.contributor.author | Çeltik, Ç | |
dc.contributor.author | Deveci, U | |
dc.contributor.author | Balci Sezer, O | |
dc.date.accessioned | 2024-07-18T12:08:45Z | |
dc.date.available | 2024-07-18T12:08:45Z | |
dc.description.abstract | Objectives: Evidence suggests that lysosomal acid lipase deficiency (LAL-D) is often underdiagnosed because symptoms may be nonspecific. We aimed to investigate the prevalence of LAL-D in children with unexplained liver disease and to identify demographic and clinical features with a prospective, multicenter, cross-sectional study. Methods: Patients (aged 3 months-18 years) who had unexplained transaminase elevation, unexplained hepatomegaly or hepatosplenomegaly, obesity-unrelated liver steatosis, biopsy-proven cryptogenic fibrosis and cirrhosis, or liver transplantation for cryptogenic cirrhosis were enrolled. A Web-based electronic data collection system was used. LAL activity (nmol/punch/h) was measured using the dried blood spot method and classified as LAL-D(<0.02), intermediate (0.02-0.37) or normal (>0.37). Asecond dried blood spot sample was obtained from patients with intermediate LAL activity for confirmation of the result. Results: A total of 810 children (median age 5.6 years) from 795 families were enrolled. The reasons for enrollment were unexplained transaminase elevation (62%), unexplained organomegaly (45%), obesity-unrelated liver steatosis (26%), cryptogenic fibrosis and cirrhosis (6%), and liver transplantation for cryptogenic cirrhosis (<1%). LAL activity was normal in 634 (78%) and intermediate in 174 (21%) patients. LAL-D was identified in 2 siblings aged 15 and 6 years born to unrelated parents. Dyslipidemia, liver steatosis, and mild increase in aminotransferases were common features in these patients. Moreover, the 15-year-old patient showed growth failure and microvesicular steatosis, portal inflammation, and bridging fibrosis in the liver biopsy. Based on 795 families, 2 siblings in the same family were identified as LAL-D cases, making the prevalence of LAL-D in this study population, 0.1% (0.125%-0.606%). In the repeated measurement (76/174), LAL activity remained at the intermediate level in 38 patients. Conclusions: Overall, the frequency of LAL-D patients in this study (0.1%) suggests that LAL-D seems to be rare even in the selected high-risk population. | |
dc.identifier.issn | 0277-2116 | |
dc.identifier.other | 1536-4801 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11059 | |
dc.language.iso | English | |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
dc.subject | ESTER STORAGE DISEASE | |
dc.subject | WOLMAN | |
dc.title | The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease | |
dc.type | Article |